Recent studies have demonstrated that urinary KIM-1 and IL-18 are potential biomarkers of early-stage AKI caused by contrast-induced nephrotoxicity, cardiac surgery, and preeclampsia [12–14], and can reveal AKI much earlier than canScr. The gene discussed is IL18; the disease is acute kidney injury.